Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Combination of plasma tumor necrosis factor receptors signaling proteins, beta-amyloid and apolipoprotein E for the detection of Alzheimer's disease.

Zhang J, Jia J, Qin W, Wang S.

Neurosci Lett. 2013 Apr 29;541:99-104. doi: 10.1016/j.neulet.2013.03.007.

PMID:
23500026
2.

Plasma amyloid-β oligomers and soluble tumor necrosis factor receptors as potential biomarkers of AD.

Zhang J, Peng M, Jia J.

Curr Alzheimer Res. 2014 May;11(4):325-31.

PMID:
24635842
3.

Elevated plasma levels of soluble TNFRs and TACE activity in Alzheimer's disease patients of Northern Han Chinese descent.

Bai L, Song N, Yu J, Tan L, Shen Y, Xie J, Jiang H.

Curr Alzheimer Res. 2013 Jan;10(1):57-62.

PMID:
23368432
4.

Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's disease.

Sun Q, Hampel H, Blennow K, Lista S, Levey A, Tang B, Li R, Shen Y.

J Alzheimers Dis. 2014;41(3):877-86. doi: 10.3233/JAD-140177.

5.

Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease.

Jiang H, Hampel H, Prvulovic D, Wallin A, Blennow K, Li R, Shen Y.

Mol Neurodegener. 2011 Oct 6;6:69. doi: 10.1186/1750-1326-6-69.

6.

Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease.

Sagare AP, Deane R, Zetterberg H, Wallin A, Blennow K, Zlokovic BV.

J Alzheimers Dis. 2011;24(1):25-34. doi: 10.3233/JAD-2010-101248.

7.

Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.

Kim HJ, Park KW, Kim TE, Im JY, Shin HS, Kim S, Lee DH, Ye BS, Kim JH, Kim EJ, Park KH, Han HJ, Jeong JH, Choi SH, Park SA.

J Alzheimers Dis. 2015;48(4):1043-50. doi: 10.3233/JAD-143018.

PMID:
26444752
8.

Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.

Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonça VA, Gattaz WF, Forlenza OV.

J Alzheimers Dis. 2010;22(4):1305-11. doi: 10.3233/JAD-2010-100921.

PMID:
20930310
9.

Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer's disease.

Han Y, Jia J, Jia XF, Qin W, Wang S.

Neurosci Lett. 2012 May 16;516(2):232-6. doi: 10.1016/j.neulet.2012.03.094.

PMID:
22503901
10.

The Relationship Between Plasma Aβ Levels, Cognitive Function and Brain Volumetrics: Sydney Memory and Ageing Study.

Poljak A, Crawford JD, Smythe GA, Brodaty H, Slavin MJ, Kochan NA, Trollor JN, Wen W, Mather KA, Assareh AA, Ng PC, Sachdev PS.

Curr Alzheimer Res. 2016;13(3):243-55.

PMID:
26679856
11.

The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.

Fei M, Jianghua W, Rujuan M, Wei Z, Qian W.

J Neurol Sci. 2011 Jun 15;305(1-2):92-6. doi: 10.1016/j.jns.2011.03.005.

PMID:
21440911
12.

Oral glucose loading modulates plasma β-amyloid level in alzheimer's disease patients: potential diagnostic method for Alzheimer's disease.

Takeda S, Sato N, Uchio-Yamada K, Yu H, Moriguchi A, Rakugi H, Morishita R.

Dement Geriatr Cogn Disord. 2012;34(1):25-30. doi: 10.1159/000338704.

PMID:
22889768
13.

Soluble tumor necrosis factor receptors shed by breast tumor cells inhibit macrophage chemotaxis.

Rego SL, Swamydas M, Kidiyoor A, Helms R, De Piante A, Lance AL, Mukherjee P, Dréau D.

J Interferon Cytokine Res. 2013 Nov;33(11):672-81. doi: 10.1089/jir.2013.0009.

PMID:
23777205
14.

Age and its association with low insulin and high amyloid-β peptides in blood.

Li H, Zhu H, Wallack M, Mwamburi M, Abdul-Hay SO, Leissring MA, Qiu WQ.

J Alzheimers Dis. 2016;49(1):129-37. doi: 10.3233/JAD-150428.

15.

The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease.

Giedraitis V, Sundelöf J, Irizarry MC, Gårevik N, Hyman BT, Wahlund LO, Ingelsson M, Lannfelt L.

Neurosci Lett. 2007 Nov 12;427(3):127-31.

PMID:
17936506
16.

New assay for old markers-plasma beta amyloid of mild cognitive impairment and Alzheimer's disease.

Chiu MJ, Yang SY, Chen TF, Chieh JJ, Huang TZ, Yip PK, Yang HC, Cheng TW, Chen YF, Hua MS, Horng HE.

Curr Alzheimer Res. 2012 Dec;9(10):1142-8.

PMID:
22950866
17.

Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study.

Morange PE, Tregouet DA, Godefroy T, Saut N, Bickel C, Rupprecht HJ, Lackner K, Barbaux S, Poirier O, Peiretti F, Nalbone G, Juhan-Vague I, Blankenberg S, Tiret L.

J Mol Med (Berl). 2008 Oct;86(10):1153-61. doi: 10.1007/s00109-008-0375-6.

PMID:
18600307
18.

Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.

Sun X, Chiu CC, Liebson E, Crivello NA, Wang L, Claunch J, Folstein M, Rosenberg I, Mwamburi DM, Peter I, Qiu WQ.

Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):238-44. doi: 10.1097/WAD.0b013e31819cb3ac.

19.

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

Wang T, Xiao S, Liu Y, Lin Z, Su N, Li X, Li G, Zhang M, Fang Y.

Int J Geriatr Psychiatry. 2014 Jul;29(7):713-9. doi: 10.1002/gps.4053.

PMID:
24318929
20.

Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia.

Uslu S, Akarkarasu ZE, Ozbabalik D, Ozkan S, Colak O, Demirkan ES, Ozkiris A, Demirustu C, Alatas O.

Neurochem Res. 2012 Jul;37(7):1554-9. doi: 10.1007/s11064-012-0750-0.

PMID:
22437436
Items per page

Supplemental Content

Support Center